期刊文献+

脓毒症的危险因素分析及预防 被引量:14

原文传递
导出
摘要 脓毒症是机体面对感染所发生的威胁生命的免疫紊乱综合征,致死率高达20%~40%,是导致近20%住院患者的主要死因。在美国,严重脓毒症占重症加强治疗病房(ICU)总患者的1/5,是ICU中非冠状动脉疾病的首要致死因素,是导致死亡的第十大疾病。到2050年,预计美国人口将增长50%,而65岁以上人群增长率超过115%。根据此增长速度估计到2020年,每6个人中就会有1个是65岁以上的老年人,这表明之后的20年中,老年人的脓毒症发病率将高达56%。现代医学在治疗脓毒症上取得了一定的成绩,我们参考国内外近两年的文献,从流行病学角度对脓毒症的危险因素及其所采取的预防措施进行综述。
出处 《中国危重病急救医学》 CAS CSCD 北大核心 2008年第1期59-61,共3页 Chinese Critical Care Medicine
基金 北京市科委重大项目(H020920020530)
  • 相关文献

参考文献18

  • 1姚咏明,盛志勇,林洪远,柴家科.脓毒症定义及诊断的新认识[J].中国危重病急救医学,2004,16(6):321-324. 被引量:310
  • 2Martin G S, Mannino D M, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000 [J]. N Engl J Med, 2003, 348 (16):1546-1554.
  • 3Parrillo J E,Parker M M,Natanson C, et al. Septic shock in humans,advances in the understanding of pathogenesis, cardiovascular dysfunction,and therapy [J]. Ann Intern Med, 1990, 113 (3): 227-242.
  • 4Arias E, Anderson R N, Kung H C et al. Deaths: final data for 2001[J]. Natl Vital Stat Rep, 2003,52 (3): 1-115.
  • 5Paz H L,Martin A A. Sepsis in an aging population[J]. Crit Care Med, 2006,34 (1) :15-21.
  • 6Martin G S,Mannino D M,Moss M. The effect of age on the development and outcome of adult sepsis[J]. Crit Care Med,2006,34(1):15-21.
  • 7Wheeler A P, Bernard G R. Treating patients with severe sepsis[J]. N Engl J Med, 1999,340(3) :207-214.
  • 8Cross A S,Opal S M. A new paradigm for the treatment of sepsis:is it time to consider combination therapy[J]? Ann Intern Med,2003,138(6) :502-505.
  • 9Angus D C,Linde Zwirble W T,Lidicker J ,et al. Epidemiology of severe sepsis in the United States:analysis of incidence, outcome, and associated costs of care[J]. Crit Care Med, 2001,29 (7) : 1303-1310.
  • 10Padkin A, Goldfrad C, Brady A R, et al. Epidemiology of severe sepsis occurring in the first 24 hours in intensive care units in England, Wales,and Northern Ireland[J]. Crit Care Med, 2003,31 (9) :2332-2338.

二级参考文献15

  • 1Bone R C,Balk R A,Cerra F B,et al.ACCP/SCCM consensus conference:definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis[J].Chest,1992,101:1644-1655.
  • 2Levy M M,Fink M P,Marshall J C,et al.2001 SCCM/ ESICM/ ACCP/ ATS/ SIS international sepsis definitions conference 1[J].Intensive Care Med,2003,29:530-538.
  • 3Angus D C,Linde-Zwirble W T,Lidicker J,et al.Epidemiology of severe sepsis in the United States:analysis of incidence:outcome,and associated costs of care[J].Crit Care Med,2001,29:1303-1310.
  • 4Linde-Zwirble W T,Angus D C.Severe sepsis epidemiology:sampling,selection,and society[J].Crit Care,2004,8:222-226.
  • 5Silva E,de Almeida P M,Sogayar A C B,et al.Brazilian Sepsis Epidemiological Study (BASES study)[J].Crit Care,2004,8:R251-R260.
  • 6Brunkhorst F M,Engel C,Reinhart K,et al.Epidemiology of severe sepsis and septic shock in Germany:results from the German′ Prevalence′ study[J].Crit Care,2005,9:196.
  • 7van Gestel A,Bakker J,Veraart C P W M,et al.Prevalence and incidence of severe sepsis in Dutch intensive care units[J].Crit Care,2004,8:R153-R162.
  • 8Flaatten H.Epidemiology of sepsis in Norway in 1999[J].Crit Care,2004,8:R180-R184.
  • 9Martin G S,Mannino D M,Eaton S,et al.The epidemiology of sepsis in the United States from 1979 through 2000[J].N Engl J Med,2003,348:1546-1554.
  • 10Padkin A,Goldfrad C,Brady A R,et al.Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England,Wales and Northern Ireland[J].Crit Care Med,2003,31:2332-2338.

共引文献338

同被引文献130

引证文献14

二级引证文献294

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部